Gires, Olivier http://orcid.org/0000-0002-2292-7064
Pan, Min
Schinke, Henrik
Canis, Martin
Baeuerle, Patrick A.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Gi540/3-2)
Bayerisches Staatsministerium für Wirtschaft und Medien, Energie und Technologie (BIO1803-0003)
Article History
First Online: 7 June 2020
Compliance with ethical standards
:
: PAB is a consultant for MPM Capital LLC, Oncology Impact Management, Harpoon Therapeutics Inc., TCR2 Therapeutics Inc., Werewolf Therapeutics Inc., iOmx Therapeutics AG, and Cullinan Oncology LLC. The other authors declare that they have no competing interests.
: Not applicable.
: Not applicable.
: Not applicable.